Ghana vs Syrian Arab Republic: Average cost of tuberculosis treatment by type
Ghana
12 constant 2022 US$
in 2024
Syrian Arab Republic
12 constant 2022 US$
in 2024
Ghana rank
45th
Syrian Arab Republic rank
45th
Average cost of tuberculosis treatment by type over time
- Ghana
- Syrian Arab Republic
How they compare
Ghana currently reports 12 constant 2022 US$ against 12 constant 2022 US$ in Syrian Arab Republic, a difference of 0 constant 2022 US$.
The two have swapped places 2 times across 5 shared years of data; in 2019 it was Syrian Arab Republic ahead.
Ghana ranks 45th and Syrian Arab Republic ranks 45th of 62 countries.
Across the 2 decades both report, Ghana averaged higher in 1 and Syrian Arab Republic in 1.
Head to head by decade
| Decade | Ghana | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 15 constant 2022 US$ | 17 constant 2022 US$ | 2 constant 2022 US$ | Syrian Arab Republic |
| 2020s | 17.25 constant 2022 US$ | 15.75 constant 2022 US$ | 1.5 constant 2022 US$ | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of tuberculosis treatment by type, Ghana or Syrian Arab Republic?
- Ghana, at 12 constant 2022 US$ against 12 constant 2022 US$ in Syrian Arab Republic as of 2024.
- What is the difference in average cost of tuberculosis treatment by type between Ghana and Syrian Arab Republic?
- 0 constant 2022 US$, with Ghana ahead.
- How many years of comparable data are there for Ghana and Syrian Arab Republic?
- 5 years are reported by both, from 2019 to 2024.
- How do Ghana and Syrian Arab Republic rank globally for average cost of tuberculosis treatment by type?
- Ghana ranks 45th and Syrian Arab Republic ranks 45th of 62 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of tuberculosis treatment by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per person starting tuberculosis preventive treatment, excluding buffer stock.